Type 1 diabetes and polyglandular autoimmune syndrome: A review
|
摘要
Type 1 diabetes(T1D) is an autoimmune disorder caused by inflammatory destruction of the pancreatic tissue. The etiopathogenesis and characteristics of the pathologic process of pancreatic destruction are well described. In addition, the putative susceptibility genes for T1 D as a monoglandular disease and the relation to polyglandular autoimmune syndrome(PAS) have also been wellexplored. The incidence of T1 D has steadily increased in most parts of the world, especially in industrialized nations. T1 D is frequently associated with autoimmune endocrine and non-endocrine diseases and patients with T1 D are at a higher risk for developing several glandular autoimmune diseases. Familial clustering is observed, which suggests that there is a genetic predisposition. Various hypotheses pertaining to viral- and bacterialinduced pancreatic autoimmunity have been proposed, however a definitive delineation of the autoimmune pathomechanism is still lacking. In patients with PAS, pancreatic and endocrine autoantigens either colocalize on one antigen-presenting cell or are expressed on two/various target cells sharing a common amino acid, which facilitates binding to and activation of T cells. The most prevalent PAS phenotype is the adult type 3 variant or PAS type Ⅲ, which encompasses T1 D and autoimmune thyroid disease. This review discusses the findings of recent studies showing noticeable differences in the genetic background and clinical phenotype of T1 D either as an isolated autoimmune endocrinopathy or within the scope of polyglandular autoimmune syndrome.
Type 1 diabetes(T1D) is an autoimmune disorder caused by inflammatory destruction of the pancreatic tissue. The etiopathogenesis and characteristics of the pathologic process of pancreatic destruction are well described. In addition, the putative susceptibility genes for T1 D as a monoglandular disease and the relation to polyglandular autoimmune syndrome(PAS) have also been wellexplored. The incidence of T1 D has steadily increased in most parts of the world, especially in industrialized nations. T1 D is frequently associated with autoimmune endocrine and non-endocrine diseases and patients with T1 D are at a higher risk for developing several glandular autoimmune diseases. Familial clustering is observed, which suggests that there is a genetic predisposition. Various hypotheses pertaining to viral- and bacterialinduced pancreatic autoimmunity have been proposed, however a definitive delineation of the autoimmune pathomechanism is still lacking. In patients with PAS, pancreatic and endocrine autoantigens either colocalize on one antigen-presenting cell or are expressed on two/various target cells sharing a common amino acid, which facilitates binding to and activation of T cells. The most prevalent PAS phenotype is the adult type 3 variant or PAS type Ⅲ, which encompasses T1 D and autoimmune thyroid disease. This review discusses the findings of recent studies showing noticeable differences in the genetic background and clinical phenotype of T1 D either as an isolated autoimmune endocrinopathy or within the scope of polyglandular autoimmune syndrome.
Type 1 diabetes(T1D) is an autoimmune disorder caused by inflammatory destruction of the pancreatic tissue. The etiopathogenesis and characteristics of the pathologic process of pancreatic destruction are well described. In addition, the putative susceptibility genes for T1 D as a monoglandular disease and the relation to polyglandular autoimmune syndrome(PAS) have also been wellexplored. The incidence of T1 D has steadily increased in most parts of the world, especially in industrialized nations. T1 D is frequently associated with autoimmune endocrine and non-endocrine diseases and patients with T1 D are at a higher risk for developing several glandular autoimmune diseases. Familial clustering is observed, which suggests that there is a genetic predisposition. Various hypotheses pertaining to viral- and bacterialinduced pancreatic autoimmunity have been proposed, however a definitive delineation of the autoimmune pathomechanism is still lacking. In patients with PAS, pancreatic and endocrine autoantigens either colocalize on one antigen-presenting cell or are expressed on two/various target cells sharing a common amino acid, which facilitates binding to and activation of T cells. The most prevalent PAS phenotype is the adult type 3 variant or PAS type Ⅲ, which encompasses T1 D and autoimmune thyroid disease. This review discusses the findings of recent studies showing noticeable differences in the genetic background and clinical phenotype of T1 D either as an isolated autoimmune endocrinopathy or within the scope of polyglandular autoimmune syndrome.
引文
1 Atkinson MA.The pathogenesis and natural history of type1 diabetes.Cold Spring Harb Perspect Med 2012;2:pii[PMID:23125199 DOI:10.1101/cshperspect.a007641]
2 Bluestone JA,Herold K,Eisenbarth G.Genetics,pathogenesis and clinical interventions in type 1 diabetes.Nature 2010;464:1293-1300[PMID:20432533]
3 Gillespie KM.Type 1 diabetes:pathogenesis and prevention.CMAJ 2006;175:165-170[PMID:16847277 DOI:10.1503/cmaj.060244]
4 Todd JA.Etiology of type 1 diabetes.Immunity 2010;32:457 -467[PMID:20412756 DOI:10.1016/j.immuni.2010.04.001]
5 Tuomilehto J.The emerging global epidemic of type 1diabetes.Curr Diab Rep 2013;13:795-804[PMID:24072479DOI:10.1007/s11892-013-0433-5]
6 DIAMOND Project Group.Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.Diabet Med 2006;23:857 -866[PMID:16911623 DOI:10.1111/j.1464-5491.2006.01925.x]
7 Cerna M,Kolostova K,Novota P,Romzova M,Cejkova P,Pinterova D,Pruhova S,Treslova L,Andel M.Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions.Ann N Y Acad Sci 2007;1110:140-150[PMID:17911429 DOI:10 .1196/annals.1423.016]
8 Xie Z,Chang C,Zhou Z.Molecular mechanisms in autoimmune type 1 diabetes:a critical review.Clin Rev Allergy Immunol 2014;47:174-192[PMID:24752371 DOI:10 .1007/s12016-014-8422-2]
9 Morahan G.Insights into type 1 diabetes provided by genetic analyses.Curr Opin Endocrinol Diabetes Obes 2012;19:263-270[PMID:22732486 DOI:10.1097/MED.0b013e328355b7fe]
10 Weinstock C,Matheis N,Barkia S,Haager MC,Janson A,MarkoviA,Bux J,Kahaly GJ.Autoimmune polyglandular syndrome type 2 shows the same HLA class II pattern as type1 diabetes.Tissue Antigens 2011;77:317-324[PMID:21388354DOI:10.1111/j.1399-0039.2011.01634.x]
11 Steck AK,Rewers MJ.Genetics of type 1 diabetes.Clin Chem 2011;57:176-185[PMID:21205883 DOI:10.1373/clinchem.2010.148221]
12 Triolo TM,Armstrong TK,Mc Fann K,Yu L,Rewers MJ,Klingensmith GJ,Eisenbarth GS,Barker JM.Additional autoimmune disease found in 33%of patients at type 1diabetes onset.Diabetes Care 2011;34:1211-1213[PMID:21430083 DOI:10.2337/dc10-1756]
13 Hansen MP,Kahaly GJ.[Autoimmune polyglandular syndromes].Dtsch Med Wochenschr 2013;138:319-326;quiz327 -328[PMID:23393002 DOI:10.1055/s-0032-1327355]
14 Frhlich-Reiterer EE,Hofer S,Kaspers S,Herbst A,Kordonouri O,Schwarz HP,Schober E,Grabert M,Holl RW.Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus--data from a German/Austrian multicentre survey.Pediatr Diabetes 2008;9:546-553[PMID:18713134 DOI:10.1111/j.1399-5448.2008.00435.x]
15 Van den Driessche A,Eenkhoorn V,Van Gaal L,De Block C.Type 1 diabetes and autoimmune polyglandular syndrome:a clinical review.Neth J Med 2009;67:376-387[PMID:20009114]
16 International Diabetes Federation.IDF Diabetes Atlas te B.Belgium:International Diabetes Federation,2013.Availablefrom:URL:http://www.idf.org/diabetesatlas
17 Tuomi T.Type 1 and type 2 diabetes:what do they have in commonDiabetes 2005;54 Suppl 2:S40-S45[PMID:16306339]
18 Atkinson MA,Eisenbarth GS,Michels AW.Type 1 diabetes.Lancet 2014;383:69-82[PMID:23890997 DOI:10.1016/S0140-6736(13)60591-7]
19 Patterson CC,Gyürüs E,Rosenbauer J,Cinek O,Neu A,Schober E,Parslow RC,Joner G,Svensson J,Castell C,Bingley PJ,Schoenle E,Jarosz-Chobot P,UrbonaitéB,Rothe U,Krzisnik C,Ionescu-Tirgoviste C,Weets I,Kocova M,Stipancic G,Samardzic M,de Beaufort CE,Green A,Dahlquist GG,Soltész G.Trends in childhood type 1 diabetes incidence in Europe during 1989-2008:evidence of nonuniformity over time in rates of increase.Diabetologia 2012;55:2142-2147[PMID:22638547 DOI:10.1007/s00125-012-2571-8]
20 Harjutsalo V,Sjberg L,Tuomilehto J.Time trends in the incidence of type 1 diabetes in Finnish children:a cohort study.Lancet 2008;371:1777-1782[PMID:18502302 DOI:10 .1016/s0140-6736(08)60765-5]
21 Patterson CC,Dahlquist GG,Gyürüs E,Green A,Soltész G.Incidence trends for childhood type 1 diabetes in Europe during1989-2003 and predicted new cases 2005-20:a multicentre prospective registration study.Lancet 2009;373:2027-2033[PMID:19481249 DOI:10.1016/s0140-6736(09)60568-7]
22 Pundziute-LyckA,Dahlquist G,Nystrm L,Arnqvist H,Bjrk E,BlohméG,Bolinder J,Eriksson JW,Sundkvist G,Ostman J.The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998.Diabetologia 2002;45:783-791[PMID:12107721 DOI:10.1007/s00125-002-0845-2]
23 Notkins AL,Lernmark A.Autoimmune type 1 diabetes:resolved and unresolved issues.J Clin Invest 2001;108:1247-1252[PMID:11696564 DOI:10.1172/jci14257]
24 Kimpimki T,Kulmala P,Savola K,Kupila A,Korhonen S,Simell T,Ilonen J,Simell O,Knip M.Natural history of betacell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.J Clin Endocrinol Metab 2002;87:4572-4579[PMID:12364437]
25 Hoppu S,Ronkainen MS,Kimpimki T,Simell S,Korhonen S,Ilonen J,Simell O,Knip M.Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes.Pediatr Res 2004;55:236-242[PMID:14605243 DOI:10.1203/01.pdr.0000100905.41131.3f]
26 Schmidli RS,De Aizpurua HJ,Harrison LC,Colman PG.Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects:relationship to age,sex and islet cell antibody status,and temporal profile.J Autoimmun 1994;7:55-66[PMID:8198702 DOI:10.1006/jaut.1994.1005]
27 Gan MJ,Albanese-O’Neill A,Haller MJ.Type 1 diabetes:current concepts in epidemiology,pathophysiology,clinical care,and research.Curr Probl Pediatr Adolesc Health Care 2012;42:269-291[PMID:23046732 DOI:10.1016/j.cppeds.2012.07.002]
28 Wenzlau JM,Juhl K,Yu L,Moua O,Sarkar SA,Gottlieb P,Rewers M,Eisenbarth GS,Jensen J,Davidson HW,Hutton JC.The cation efflux transporter Zn T8(Slc30A8)is a major autoantigen in human type 1 diabetes.Proc Natl Acad Sci USA 2007;104:17040-17045[PMID:17942684 DOI:10.1073/pnas.0705894104]
29 Foulis AK,Mc Gill M,Farquharson MA.Insulitis in type 1(insulin-dependent)diabetes mellitus in man--macrophages,lymphocytes,and interferon-gamma containing cells.J Pathol 1991;165:97-103[PMID:1744803 DOI:10.1002/path.1711650203]
30 Santamaria P.The long and winding road to understanding and conquering type 1 diabetes.Immunity 2010;32:437-445[PMID:20412754 DOI:10.1016/j.immuni.2010.04.003]
31 Li M,Song L J,Qin X Y.Advances in the cell ular immunological pathogenesis of type 1 diabetes.J Cell Mol Med 2014;18:749-758[PMID:24629100 DOI:10.1111/jcmm.12270]
32 Cutolo M,Paolino S,Sulli A,Smith V,Pizzorni C,Seriolo B.Vitamin D,steroid hormones,and autoimmunity.Ann N Y Acad Sci 2014;1317:39-46[PMID:24739090 DOI:10.1111/nyas.12432]
33 Keenan HA,Sun JK,Levine J,Doria A,Aiello LP,Eisenbarth G,Bonner-Weir S,King GL.Residual insulin production and pancreatic-cell turnover after 50 years of diabetes:Joslin Medalist Study.Diabetes 2010;59:2846-2853[PMID:20699420DOI:10.2337/db10-0676]
34 Gianani R.Beta cell regeneration in human pancreas.Semin Immunopathol 2011;33:23-27[PMID:21188381 DOI:10.1007/s00281-010-0235-7]
35 Kyvik KO,Green A,Beck-Nielsen H.Concordance rates of insulin dependent diabetes mellitus:a population based study of young Danish twins.BMJ 1995;311:913-917[PMID:7580548 DOI:10.1136/bmj.311.7010.913]
36 Hyttinen V,Kaprio J,Kinnunen L,Koskenvuo M,Tuomilehto J.Genetic liability of type 1 diabetes and the onset age among22 ,650 young Finnish twin pairs:a nationwide follow-up study.Diabetes 2003;52:1052-1055[PMID:12663480 DOI:10 .2337/diabetes.52.4.1052]
37 Risch N.Assessing the role of HLA-linked and unlinked determinants of disease.Am J Hum Genet 1987;40:1-14[PMID:3468804]
38 Pociot F,Mc Dermott MF.Genetics of type 1 diabetes mellitus.Genes Immun 2002;3:235-249[PMID:12140742 DOI:10.1038/sj.gene.6363875]
39 Singal DP,Blajchman MA.Histocompatibility(HL-A)antigens,lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus.Diabetes 1973;22:429-432[PMID:4541338]
40 Buzzetti R,Quattrocchi CC,NisticòL.Dissecting the genetics of type 1 diabetes:relevance for familial clustering and differences in incidence.Diabetes Metab Rev 1998;14:111-128[PMID:9679666]
41 Cudworth AG,Wolf E.The genetics of Type 1(insulindependent)diabetes.Curr Probl Clin Biochem 1983;12:45-64[PMID:6418443]
42 Nguyen C,Varney MD,Harrison LC,Morahan G.Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms.Diabetes2013;62:2135-2140[PMID:23378606 DOI:10.2337/db12-1398]
43 Kockum I,Sanjeevi CB,Eastman S,Landin-Olsson M,Dahlquist G,Lernmark A.Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes.Eur J Immunogenet 1999;26:361-372[PMID:10553503 DOI:10 .1046/j.1365-2370.1999.00173.x]
44 Platz P,Jakobsen BK,Morling N,Ryder LP,Svejgaard A,Thomsen M,Christy M,Kromann H,Benn J,Nerup J,Green A,Hauge M.HLA-D and-DR antigens in genetic analysis of insulin dependent diabetes mellitus.Diabetologia 1981;21:108 -115[PMID:6167481 DOI:10.1007/BF00251276]
45 Undlien DE,Lie BA,Thorsby E.HLA complex genes in type1 diabetes and other autoimmune diseases.Which genes are involvedTrends Genet 2001;17:93-100[PMID:11173119 DOI:10 .1016/S0168-9525(00)02180-6]
46 Steck AK,Bugawan TL,Valdes AM,Emery LM,Blair A,Norris JM,Redondo MJ,Babu SR,Erlich HA,Eisenbarth GS,Rewers MJ.Association of non-HLA genes with type 1diabetes autoimmunity.Diabetes 2005;54:2482-2486[PMID:16046318 DOI:10.2337/diabetes.54.8.2482]
47 Knip M,Simell O.Environmental triggers of type 1 diabetes.Cold Spring Harb Perspect Med 2012;2:a007690[PMID:22762021 DOI:10.1101/cshperspect.a007690]
48 Variation and trends in incidence of childhood diabetes in Europe.EURODIAB ACE Study Group.Lancet 2000;355:873 -876 [PMID:10752702]
49 Afonso G,Mallone R.Infectious triggers in type 1 diabetes:is there a case for epitope mimicryDiabetes Obes Metab 2013;15Suppl 3:82-88[PMID:24003924 DOI:10.1111/dom.12166]
50 Luopajrvi K,Savilahti E,Virtanen SM,Ilonen J,Knip M,Akerblom HK,Vaarala O.Enhanced levels of cow’s milk antibodies in infancy in children who develop type 1 diabetes later in childhood.Pediatr Diabetes 2008;9:434-441[PMID:18503496 DOI:10.1111/j.1399-5448.2008.00413.x]
51 Howard SG,Lee DH.What is the role of human contamination by environmental chemicals in the development of type 1diabetesJ Epidemiol Community Health 2012;66:479-481[PMID:21502091 DOI:10.1136/jech.2011.133694]
52 Mac Farlane AJ,Strom A,Scott FW.Epigenetics:deciphering how environmental factors may modify autoimmune type 1diabetes.Mamm Genome 2009;20:624-632[PMID:19697079DOI:10.1007/s00335-009-9213-6]
53 Perros P,Mc Crimmon RJ,Shaw G,Frier BM.Frequency of thyroid dysfunction in diabetic patients:value of annual screening.Diabet Med 1995;12:622-627[PMID:7554786 DOI:10 .1111/j.1464-5491.1995.tb00553.x]
54 Barera G,Bonfanti R,Viscardi M,Bazzigaluppi E,Calori G,Meschi F,Bianchi C,Chiumello G.Occurrence of celiac disease after onset of type 1 diabetes:a 6-year prospective longitudinal study.Pediatrics 2002;109:833-838[PMID:11986443 DOI:10.1542/peds.109.5.833]
55 Barker JM.Clinical review:Type 1 diabetes-associated autoimmunity:natural history,genetic associations,and screening.J Clin Endocrinol Metab 2006;91:1210-1217[PMID:16403820 DOI:10.1210/jc.2005-1679]
56 Barker JM,Yu J,Yu L,Wang J,Miao D,Bao F,Hoffenberg E,Nelson JC,Gottlieb PA,Rewers M,Eisenbarth GS.Autoantibody“subspecificity”in type 1 diabetes:risk for organ-specific autoimmunity clusters in distinct groups.Diabetes Care 2005;28:850-855[PMID:15793184]
57 Liao KP,Gunnarsson M,Kllberg H,Ding B,Plenge RM,Padyukov L,Karlson EW,Klareskog L,Askling J,Alfredsson L.Specific association of type 1 diabetes mellitus with anticyclic citrullinated peptide-positive rheumatoid arthritis.Arthritis Rheum 2009;60:653-660[PMID:19248096 DOI:10 .1002/art.24362]
58 Van Hattem S,Bootsma AH,Thio HB.Skin manifestations of diabetes.Cleve Clin J Med 2008;75:772,774,776-777 passim[PMID:19068958]
59 Nielsen NM,Westergaard T,Frisch M,Rostgaard K,Wohlfahrt J,Koch-Henriksen N,Melbye M,Hjalgrim H.Type 1 diabetes and multiple sclerosis:A Danish populationbased cohort study.Arch Neurol 2006;63:1001-1004[PMID:16831970 DOI:10.1001/archneur.63.7.1001]
60 Kota SK,Meher LK,Jammula S,Kota SK,Modi KD.Clinical profile of coexisting conditions in type 1 diabetes mellitus patients.Diabetes Metab Syndr 2012;6:70-76[PMID:23153973DOI:10.1016/j.dsx.2012.08.006]
61 Mazzarella G,Stefanile R,Camarca A,Giliberti P,Cosentini E,Marano C,Iaquinto G,Giardullo N,Auricchio S,Sette A,Troncone R,Gianfrani C.Gliadin activates HLA class I-restricted CD8+T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.Gastroenterology2008;134:1017-1027[PMID:18395083 DOI:10.1053/j.gastro.2008.01.008]
62 Hermann R,Turpeinen H,Laine AP,Veijola R,Knip M,Simell O,SipilI,Akerblom HK,Ilonen J.HLA DR-DQencoded genetic determinants of childhood-onset type 1diabetes in Finland:an analysis of 622 nuclear families.Tissue Antigens 2003;62:162-169[PMID:12889996]
63 Kooy-Winkelaar Y,van Lummel M,Moustakas AK,Schweizer J,Mearin ML,Mulder CJ,Roep BO,Drijfhout JW,Papadopoulos GK,van Bergen J,Koning F.Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8βtransdimer.J Immunol 2011;187:5123-5129[PMID:22013116 DOI:10.4049/jimmunol.1101179]
64 Troncone R,Discepolo V.Celiac disease and autoimmunity.J Pediatr Gastroenterol Nutr 2014;59 Suppl 1:S9-S11[PMID:24979198 DOI:10.1097/01.mpg.0000450394.30780.ea]
65 Antvorskov JC,Fundova P,Buschard K,Funda DP.Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.PLo S One 2012;7:e33315[PMID:22428018DOI:10.1371/journal.pone.0033315]
66 Cohn A,Sofia AM,Kupfer SS.Type 1 diabetes and celiac disease:clinical overlap and new insights into disease pathogenesis.Curr Diab Rep 2014;14:517[PMID:24952108DOI:10.1007/s11892-014-0517-x]
67 Alonso N,Soldevila B,SanmartíA,Pujol-Borrell R,MartínezCáceres E.Regulatory T cells in diabetes and gastritis.Autoimmun Rev 2009;8:659-662[PMID:19393198 DOI:10 .1016/j.autrev.2009.02.014]
68 Kahaly GJ.Polyglandular autoimmune syndromes.Eur J Endocrinol 2009;161:11-20[PMID:19411300 DOI:10.1530/eje-09-0044]
69 Neufeld M,Maclaren N,Blizzard R.Autoimmune polyglandular syndromes.Pediatr Ann 1980;9:154-162[PMID:6990358]
70 Betterle C,Zanchetta R.Update on autoimmune polyendocrine syndromes(APS).Acta Biomed 2003;74:9-33[PMID:12817789]
71 Betterle C,Greggio NA,Volpato M.Clinical review 93:Autoimmune polyglandular syndrome type 1.J Clin Endocrinol Metab 1998;83:1049-1055[PMID:9543115 DOI:10 .1210/jcem.83.4.4682]
72 Ahonen P,Myllrniemi S,SipilI,Perheentupa J.Clinical variation of autoimmune polyendocrinopathy-candidiasisectodermal dystrophy(APECED)in a series of 68 patients.N Engl J Med 1990;322:1829-1836[PMID:2348835 DOI:10 .1056/nejm199006283222601]
73 Tuomi T,Bjrses P,Falorni A,Partanen J,Perheentupa J,Lernmark A,Miettinen A.Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.J Clin Endocrinol Metab 1996;81:1488-1494[PMID:8636356 DOI:10 .1210/jcem.81.4.8636356]
74 Perheentupa J,Miettinen A.Type 1 autoimmune polyglandular disease.Ann Med Interne(Paris)1999;150:313-325[PMID:10519019]
75 Neufeld M,Maclaren NK,Blizzard RM.Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune(PGA)syndromes.Medicine(Baltimore)1981;60:355-362[PMID:7024719 DOI:10.1097/00005792-198109000-00003]
76 Zlotogora J,Shapiro MS.Polyglandular autoimmune syndrome type I among Iranian Jews.J Med Genet 1992;29:824 -826[PMID:1453436 DOI:10.1136/jmg.29.11.824]
77 Sato K,Nakajima K,Imamura H,Deguchi T,Horinouchi S,Yamazaki K,Yamada E,Kanaji Y,Takano K.A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy,candidiasis and ectodermal dystrophy(APECED),accompanied with progressive muscular atrophy:case report and review of the literature in Japan.Endocr J 2002;49 :625-633[PMID:12625412 DOI:10.1507/endocrj.49.625]
78 Betterle C,Dal Pra C,Mantero F,Zanchetta R.Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes:autoantibodies,autoantigens,and their applicability in diagnosis and disease prediction.Endocr Rev 2002;23:327-364[PMID:12050123 DOI:10.1210/edrv.23.3.0466]
79 Gylling M,Tuomi T,Bjrses P,Kontiainen S,Partanen J,Christie MR,Knip M,Perheentupa J,Miettinen A.ss-cell autoantibodies,human leukocyte antigen II alleles,and type1 diabetes in autoimmune polyendocrinopathy-candidiasisectodermal dystrophy.J Clin Endocrinol Metab 2000;85:4434-4440[PMID:11134089 DOI:10.1210/jcem.85.12.7120]
80 Bjrk E,Velloso LA,Kmpe O,Karlsson FA.GAD autoantibodies in IDDM,stiff-man syndrome,and autoimmune polyendocrinesyndrome type I recognize different epitopes.Diabetes 1994;43:161 -165[PMID:7505244]
81 Velloso LA,Winqvist O,Gustafsson J,Kmpe O,Karlsson FA.Autoantibodies against a novel 51 k Da islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.Diabetologia 1994;37:61-69[PMID:8150232]
82 Husebye ES,Gebre-Medhin G,Tuomi T,Perheentupa J,Landin-Olsson M,Gustafsson J,Rorsman F,Kmpe O.Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I.J Clin Endocrinol Metab 1997;82:147-150[PMID:8989249 DOI:10 .1210/jcem.82.1.3647]
83 Rorsman F,Husebye ES,Winqvist O,Bjrk E,Karlsson FA,Kmpe O.Aromatic-L-amino-acid decarboxylase,a pyridoxal phosphate-dependent enzyme,is a beta-cell autoantigen.Proc Natl Acad Sci USA 1995;92:8626-8629[PMID:7567987]
84 Anaya JM.Common mechanisms of autoimmune diseases(the autoimmune tautology).Autoimmun Rev 2012;11:781 -784[PMID:22353402 DOI:10.1016/j.autrev.2012.02.002]
85 Miller FW.Environmental agents and autoimmune diseases.Adv Exp Med Biol 2011;711:61-81[PMID:21627043]
86 Selmi C.Autoimmunity in 2011.Clin Rev Allergy Immunol2012;43:194-206[PMID:22733376DOI101007/s12016-012-8330-2]
87 Anaya JM.The diagnosis and clinical significance of polyautoimmunity.Autoimmun Rev 2014;13:423-426[PMID:24424171DOI:10.1016/j.autrev.2014.01.049]
88 Cutolo M.Autoimmune polyendocrine syndromes.Autoimmun Rev 2014;13:85-89[PMID:24055063 DOI:10.1016/j.autrev.2013.07.006]
89 Erichsen MM,Lvs K,Skinningsrud B,Wolff AB,Undlien DE,Svartberg J,Fougner KJ,Berg TJ,Bollerslev J,Mella B,Carlson JA,Erlich H,Husebye ES.Clinical,immunological,and genetic features of autoimmune primary adrenal insufficiency:observations from a Norwegian registry.J Clin Endocrinol Metab 2009;94:4882-4890[PMID:19858318 DOI:10 .1210/jc.2009-1368]
90 Betterle C,Morlin L.Autoimmune Addison’s disease.Endocr Dev 2011;20:161-172[PMID:21164269 DOI:10.1159/000321239]
91 Brenta G.Diabetes and thyroid disorders.Br J Diabetes Vasc Dis 2010;10:172-177[DOI:10.1177/1474651410371321]
92 Duntas LH,Orgiazzi J,Brabant G.The interface between thyroid and diabetes mellitus.Clin Endocrinol(Oxf)2011;75:1 -9[PMID:21521298 DOI:10.1111/j.1365-2265.2011.04029.x]
93 Kadiyala R,Peter R,Okosieme OE.Thyroid dysfunction in patients with diabetes:clinical implications and screening strategies.Int J Clin Pract 2010;64:1130-1139[PMID:20642711DOI:10.1111/j.1742-1241.2010.02376.x]
94 Kordonouri O,Klinghammer A,Lang EB,Grüters-Kieslich A,Grabert M,Holl RW.Thyroid autoimmunity in children and adolescents with type 1 diabetes:a multicenter survey.Diabetes Care 2002;25:1346-1350[PMID:12145233]
95 Denzer C,Karges B,Nke A,Rosenbauer J,Schober E,Schwab KO,Holl RW.Subclinical hypothyroidism and dyslipidemia in children and adolescents with type 1 diabetes mellitus.Eur J Endocrinol 2013;168:601-608[PMID:23384709DOI:10.1530/eje-12-0703]
96 Riley WJ,Maclaren NK,Lezotte DC,Spillar RP,Rosenbloom AL.Thyroid autoimmunity in insulin-dependent diabetes mellitus:the case for routine screening.J Pediatr 1981;99:350 -354[PMID:7264787]
97 Roldán MB,Alonso M,Barrio R.Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus.Diabetes Nutr Metab 1999;12:27-31[PMID:10517303]
98 Lambadiari V,Mitrou P,Maratou E,Raptis AE,Tountas N,Raptis SA,Dimitriadis G.Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes.Endocrine 2011;39:28-32[PMID:21072691DOI:10.1007/s12020-010-9408-3]
99 Horie I,Kawasaki E,Ando T,Kuwahara H,Abiru N,Usa T,Yamasaki H,Ejima E,Kawakami A.Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population.J Clin Endocrinol Metab 2012;97:E1043-E1050[PMID:22466347 DOI:10.1210/jc.2011-3109]
100 Boelaert K,Newby PR,Simmonds MJ,Holder RL,CarrSmith JD,Heward JM,Manji N,Allahabadia A,Armitage M,Chatterjee KV,Lazarus JH,Pearce SH,Vaidya B,Gough SC,Franklyn JA.Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.Am J Med 2010;123:183.e1-183.e9[PMID:20103030DOI:10.1016/j.amjmed.2009.06.030]
101 Lupi I,Raffaelli V,Di Cianni G,Caturegli P,Manetti L,Ciccarone AM,Bogazzi F,Mariotti S,Del Prato S,Martino E.Pituitary autoimmunity in patients with diabetes mellitus and other endocrine disorders.J Endocrinol Invest 2013;36:127 -131[PMID:23481612 DOI:10.1007/BF03346747]
102 Yoshioka K,Ohsawa A,Yoshida T,Yokoh S.Insulindependent diabetes mellitus associated with Graves’disease and idiopathic hypoparathyroidism.J Endocrinol Invest 1993;16 :643-646[PMID:8258654 DOI:10.1007/BF03347687]
103 Shapiro MS,Zamir R,Weiss E,Radnay J,Shenkman L.The polyglandular deficiency syndrome:a new variant in Persian Jews.J Endocrinol Invest 1987;10:1-7[PMID:3496374 DOI:10 .1007/BF03347139]
104 Frster G,Krummenauer F,Kühn I,Beyer J,Kahaly G.[Polyglandular autoimmune syndrome type II:epidemiology and forms of manifestation].Dtsch Med Wochenschr 1999;124:1476-1481[PMID:10629665 DOI:10.1055/s-2008-1035684]
105 Dittmar M,Kahaly GJ.Polyglandular autoimmune syndromes:immunogenetics and long-term follow-up.J Clin Endocrinol Metab 2003;88:2983-2992[PMID:12843130 DOI:10 .1210/jc.2002-021845]
106 Schatz DA,Winter WE.Autoimmune polyglandular syndrome.II:Clinical syndrome and treatment.Endocrinol Metab Clin North Am 2002;31:339-352[PMID:12092454]
107 Santamaria P,Barbosa JJ,Lindstrom AL,Lemke TA,Goetz FC,Rich SS.HLA-DQB1-associated susceptibility that distinguishes Hashimoto‘s thyroiditis from Graves‘disease in type I diabetic patients.J Clin Endocrinol Metab 1994;78:878 -883[PMID:8157715 DOI:10.1210/jcem.78.4.8157715]
108 Huang W,Connor E,Rosa TD,Muir A,Schatz D,Silverstein J,Crockett S,She JX,Maclaren NK.Although DR3-DQB1*0201may be associated with multiple component diseases of the autoimmune polyglandular syndromes,the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in betacell autoimmunity.J Clin Endocrinol Metab 1996;81:2559-2563[PMID:8675578 DOI:10.1210/jcem.81.7.8675578]
109 Chikuba N,Akazawa S,Yamaguchi Y,Kawasaki E,Takino H,Yoshimoto M,Ohe N,Yamashita K,Yano A,Nagataki S.Immunogenetic heterogeneity in type 1(insulin-dependent)diabetes among Japanese--class II antigen and autoimmune thyroid disease.Diabetes Res Clin Pract 1995;27:31-37[PMID:7781492 DOI:10.1016/0168-8227(94)01025-U]
110 Chuang LM,Wu HP,Chang CC,Tsai WY,Chang HM,Tai TY,Lin BJ.HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus.Clin Endocrinol(Oxf)1996;45:631-636[PMID:8977762 DOI:10.1046/j.1365-2265.1996.00857.x]
111 Kim EY,Shin CH,Yang SW.Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease.Autoimmunity 2003;36 :177-181[PMID:12911285 DOI:10.1080/0891693031000101279]
112 Golden B,Levin L,Ban Y,Concepcion E,Greenberg DA,Tomer Y.Genetic analysis of families with autoimmune diabetes and thyroiditis:evidence for common and unique genes.J Clin Endocrinol Metab 2005;90:4904-4911[PMID:15928253 DOI:10.1210/jc.2004-2236]
113 Villano MJ,Huber AK,Greenberg DA,Golden BK,Concepcion E,Tomer Y.Autoimmune thyroiditis and diabetes:dissecting the joint genetic susceptibility in a large cohort of multiplex families.J Clin Endocrinol Metab 2009;94:1458-1466[PMID:19141582 DOI:10.1210/jc.2008-2193]
114 Dultz G,Matheis N,Dittmar M,Bender K,Kahaly GJ.CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity.Horm Metab Res 2009;41:426-429[PMID:19530270]
115 Awata T,Kawasaki E,Tanaka S,Ikegami H,Maruyama T,Shimada A,Nakanishi K,Kobayashi T,Iizuka H,Uga M,Kawabata Y,Kanazawa Y,Kurihara S,Osaki M,Katayama S.Association of type 1 diabetes with two Loci on 12q13 and16 p13 and the influence coexisting thyroid autoimmunity in Japanese.J Clin Endocrinol Metab 2009;94:231-235[PMID:18940880 DOI:10.1210/jc.2008-0718]
116 Dultz G,Matheis N,Dittmar M,Rhrig B,Bender K,Kahaly GJ.The protein tyrosine phosphatase non-receptor type22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.Thyroid 2009;19 :143-148[PMID:19090780 DOI:10.1089/thy.2008.0301]
117 Smyth D,Cooper JD,Collins JE,Heward JM,Franklyn JA,Howson JM,Vella A,Nutland S,Rance HE,Maier L,Barratt BJ,Guja C,Ionescu-Trgoviste C,Savage DA,Dunger DB,Widmer B,Strachan DP,Ring SM,Walker N,Clayton DG,Twells RC,Gough SC,Todd JA.Replication of an association between the lymphoid tyrosine phosphatase locus(LYP/PTPN22)with type 1 diabetes,and evidence for its role as a general autoimmunity locus.Diabetes 2004;53:3020-3023[PMID:15504986]
118 Kawasaki E,Awata T,Ikegami H,Kobayashi T,Maruyama T,Nakanishi K,Shimada A,Uga M,Kurihara S,Kawabata Y,Tanaka S,Kanazawa Y,Lee I,Eguchi K.Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene(PTPN22):association between a promoter polymorphism and type 1 diabetes in Asian populations.Am J Med Genet A 2006;140:586-593[PMID:16470599 DOI:10 .1002/ajmg.a.31124]
119 Bottini N,Musumeci L,Alonso A,Rahmouni S,Nika K,Rostamkhani M,Mac Murray J,Meloni GF,Lucarelli P,Pellecchia M,Eisenbarth GS,Comings D,Mustelin T.A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.Nat Genet 2004;36:337-338[PMID:15004560 DOI:10.1038/ng1323]
120 van der Vliet HJ,Nieuwenhuis EE.IPEX as a result of mutations in FOXP3.Clin Dev Immunol 2007;2007:89017[PMID:18317533 DOI:10.1155/2007/89017]
121 Wildin RS,Smyk-Pearson S,Filipovich AH.Clinical and molecular features of the immunodysregulation,polyendocrinopathy,enteropathy,X linked(IPEX)syndrome.J Med Genet 2002;39:537-545[PMID:12161590]
122 Long SA,Cerosaletti K,Bollyky PL,Tatum M,Shilling H,Zhang S,Zhang ZY,Pihoker C,Sanda S,Greenbaum C,Buckner JH.Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+)regulatory T-cells of type 1 diabetic subjects.Diabetes 2010;59:407-415[PMID:19875613 DOI:10.2337/db09-0694]
123 Husebye ES,Anderson MS.Autoimmune polyendocrine syndromes:clues to type 1 diabetes pathogenesis.Immunity 2010;32 :479-487[PMID:20412758 DOI:10.1016/j.immuni.2010.03.016]
124 Tomer Y,Menconi F.Type 1 diabetes and autoimmune thyroiditis:the genetic connection.Thyroid 2009;19:99-102[PMID:19191741 DOI:10.1089/thy.2008.1565]
125 Bingley PJ,Christie MR,Bonifacio E,Bonfanti R,Shattock M,Fonte MT,Bottazzo GF,Gale EA.Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.Diabetes 1994;43:1304-1310[PMID:7926304]
126 Deja G,Myrda A,Jarosz-Chobot P,Siekiera U.The assessment of autoimmunological status and prevalence ofdifferent forms of celiac disease among children with type 1diabetes mellitus and celiac disease.Mediators Inflamm 2008;2008:285989[PMID:18437226 DOI:10.1155/2008/285989]
127 Irvine WJ,Mc Callum CJ,Gray RS,Campbell CJ,Duncan LJ,Farquhar JW,Vaughan H,Morris PJ.Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes,coexistent autoimmune disease,and HLA type.Diabetes 1977;26:138-147[PMID:320073]
128 Kawasaki E.Zn T8 and type 1 diabetes.Endocr J 2012;59:531 -537[PMID:22447136]
129 Orban T,Sosenko JM,Cuthbertson D,Krischer JP,Skyler JS,Jackson R,Yu L,Palmer JP,Schatz D,Eisenbarth G.Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.Diabetes Care 2009;32 :2269-2274[PMID:19741189 DOI:10.2337/dc09-0934]
130 Petruzelkova L,Ananieva-Jordanova R,Vcelakova J,Vesely Z,Stechova K,Lebl J,Dusatkova P,Sumnik Z,Coles R,Powell M,Furmaniak J,Rees Smith B,Kolouskova S.The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.Diabet Med 2014;31:165-171[PMID:23952619 DOI:10.1111/dme.12308]
131 Skrstrand H,Lernmark A,Vaziri-Sani F.Antigenicity and epitope specificity of Zn T8 autoantibodies in type 1 diabetes.Scand J Immunol 2013;77:21-29[PMID:23126564 DOI:10 .1111/sji.12008]
132 Trn C,Mueller PW,Schlosser M,Bonifacio E,Bingley PJ.Diabetes Antibody Standardization Program:evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.Diabetologia 2008;51:846-852[PMID:18373080DOI:10.1007/s00125-008-0967-2]
133 Vaziri-Sani F,Oak S,Radtke J,Lernmark K,Lynch K,Agardh CD,Cilio CM,Lethagen AL,Ortqvist E,LandinOlsson M,Trn C,Hampe CS.Zn T8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.Autoimmunity 2010;43:598-606[PMID:20298127 DOI:10.3109 /08916930903555927]
134 Zhang L,Eisenbarth GS.Prediction and prevention of Type1 diabetes mellitus.J Diabetes 2011;3:48-57[PMID:21073664DOI:10.1111/j.1753-0407.2010.00102.x]
135 Thomson G,Robinson WP,Kuhner MK,Joe S,Mac Donald MJ,Gottschall JL,Barbosa J,Rich SS,Bertrams J,Baur MP.Genetic heterogeneity,modes of inheritance,and risk estimates for a joint study of Caucasians with insulindependent diabetes mellitus.Am J Hum Genet 1988;43:799 -816[PMID:3057885]
136 Cooper GS,Bynum ML,Somers EC.Recent insights in the epidemiology of autoimmune diseases:improved prevalence estimates and understanding of clustering of diseases.J Autoimmun 2009;33:197-207[PMID:19819109 DOI:10.1016/j.jaut.2009.09.008]
137 Unnikrishnan AG,Kumaravel V,Nair V,Rao A,Jayakumar RV,Kumar H,Sanjeevi CB.TSH receptor antibodies in subjects with type 1 diabetes mellitus.Ann N Y Acad Sci 2006;1079:220-225[PMID:17130558 DOI:10.1196/annals.1375.034]
138 Premawardhana LD,Wijeyaratne CN,Chen S,Wijesuriya M,Illangasekera U,Brooking H,Amoroso M,Jeffreys J,Bolton J,Lazarus JH,Furmaniak J,Rees Smith B.Islet cell,thyroid,adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.J Endocrinol Invest 2006;29 :968-974[PMID:17259793]
139 Orgiazzi J.Anti-TSH receptor antibodies in clinical practice.Endocrinol Metab Clin North Am 2000;29:339-355,vii[PMID:10874533]
140 Pinto AL,Dantas JR,Araujo D,Barone B,de Souza Papi J,de Oliveira JE,Zajdenverg L,Rodacki M.Anti-parietal cell antibodies and pernicious anemia in patients with type 1diabetes mellitus and multiethnic background.Diabetes Res Clin Pract 2013;102:e41-e43[PMID:24083984 DOI:10.1016/j.diabres.2013.08.008]
141 Perros P,Singh RK,Ludlam CA,Frier BM.Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease.Diabet Med 2000;17:749 -751[PMID:11110510]
142 Caturegli P,Newschaffer C,Olivi A,Pomper MG,Burger PC,Rose NR.Autoimmune hypophysitis.Endocr Rev 2005;26 :599-614[PMID:15634713 DOI:10.1210/er.2004-0011]
143 Lvs K,Husebye ES.High prevalence and increasing incidence of Addison’s disease in western Norway.Clin Endocrinol(Oxf)2002;56:787-791[PMID:12072049]
144 Ban Y,Davies TF,Greenberg DA,Concepcion ES,Tomer Y.The influence of human leucocyte antigen(HLA)genes on autoimmune thyroid disease(AITD):results of studies in HLA-DR3 positive AITD families.Clin Endocrinol(Oxf)2002;57 :81-88[PMID:12100074]
145 Brozzetti A,Marzotti S,Tortoioli C,Bini V,Giordano R,Dotta F,Betterle C,De Bellis A,Arnaldi G,Toscano V,Arvat E,Bellastella A,Mantero F,Falorni A.Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency:Italian association study and meta-analysis of European studies.Eur J Endocrinol 2010;162 :361-369[PMID:19884265 DOI:10.1530/eje-09-0618]
146 Criswell LA,Pfeiffer KA,Lum RF,Gonzales B,Novitzke J,Kern M,Moser KL,Begovich AB,Carlton VE,Li W,Lee AT,Ortmann W,Behrens TW,Gregersen PK.Analysis of families in the multiple autoimmune disease genetics consortium(MADGC)collection:the PTPN22 620W allele associates with multiple autoimmune phenotypes.Am J Hum Genet 2005;76:561 -571[PMID:15719322 DOI:10.1086/429096]
147 Gambelunghe G,Falorni A,Ghaderi M,Laureti S,Tortoioli C,Santeusanio F,Brunetti P,Sanjeevi CB.Microsatellite polymorphism of the MHC class I chain-related(MIC-A and MIC-B)genes marks the risk for autoimmune Addison’s disease.J Clin Endocrinol Metab 1999;84:3701-3707[PMID:10523017 DOI:10.1210/jcem.84.10.6069]
148 Heward JM,Allahabadia A,Daykin J,Carr-Smith J,Daly A,Armitage M,Dodson PM,Sheppard MC,Barnett AH,Franklyn JA,Gough SC.Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves’disease:replication using a population case control and family-based study.J Clin Endocrinol Metab 1998;83:3394-3397[PMID:9768636DOI:10.1210/jcem.83.10.5137]
149 Ide M,Dittmar M,Wurm M,Kanitz M,Kahaly GJ.[Polymorphisms of MICA microsatellites in thyroidal autoimmunity].Med Klin(Munich)2007;102:11-15[PMID:17221346 DOI:10 .1007/s00063-007-1001-z]
150 Kavvoura FK,Ioannidis JP.CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus:a Hu GE Review and meta-analysis.Am J Epidemiol 2005;162:3-16[PMID:15961581 DOI:10.1093/aje/kwi165]
151 Menconi F,Monti MC,Greenberg DA,Oashi T,Osman R,Davies TF,Ban Y,Jacobson EM,Concepcion ES,Li CW,Tomer Y.Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice.Proc Natl Acad Sci USA 2008;105:14034-14039[PMID:18779568 DOI:10.1073/pnas.0806584105]
152 Park Y,Lee H,Sanjeevi CB,Eisenbarth GS.MICA polymorphism is associated with type 1 diabetes in the Korean population.Diabetes Care 2001;24:33-38[PMID:11194237]
153 Roycroft M,Fichna M,Mc Donald D,Owen K,Zurawek M,Gryczyńska M,Januszkiewicz-Lewandowska D,Fichna P,Cordell H,Donaldson P,Nowak J,Pearce S.The tryptophan620 allele of the lymphoid tyrosine phosphatase(PTPN22)gene predisposes to autoimmune Addison’s disease.Clin Endocrinol(Oxf)2009;70:358-362[PMID:18710467 DOI:10 .1111/j.1365-2265.2008.03380.x]
154 Saleh HM,Rohowsky N,Leski M.The CTLA4-819 C/T and+49 A/G dimorphisms are associated with Type 1 diabetes in Egyptian children.Indian J Hum Genet 2008;14:92-98[PMID:20300303 DOI:10.4103/0971-6866.45001]
155 Sanjeevi CB,Sedimbi SK,Landin-Olsson M,Kockum I,Lernmark A.Risk conferred by HLA-DR and DQ for type1 diabetes in 0-35-year age group in Sweden.Ann N Y Acad Sci 2008;1150:106-111[PMID:19120278 DOI:10.1196/annals.1447.061]
156 Stenszky V,Kozma L,Balázs C,Rochlitz S,Bear JC,Farid NR.The genetics of Graves’disease:HLA and disease susceptibility.J Clin Endocrinol Metab 1985;61:735-740[PMID:3861611 DOI:10.1210/jcem-61-4-735]
157 Thorsby E.Invited anniversary review:HLA associated diseases.Hum Immunol 1997;53:1-11[PMID:9127141 DOI:10 .1016/s0198-8859(97)00024-4]
158 Ueda H,Howson JM,Esposito L,Heward J,Snook H,Chamberlain G,Rainbow DB,Hunter KM,Smith AN,Di Genova G,Herr MH,Dahlman I,Payne F,Smyth D,Lowe C,Twells RC,Howlett S,Healy B,Nutland S,Rance HE,Everett V,Smink LJ,Lam AC,Cordell HJ,Walker NM,Bordin C,Hulme J,Motzo C,Cucca F,Hess JF,Metzker ML,Rogers J,Gregory S,Allahabadia A,Nithiyananthan R,TuomilehtoWolf E,Tuomilehto J,Bingley P,Gillespie KM,Undlien DE,Rnningen KS,Guja C,Ionescu-Trgovite C,Savage DA,Maxwell AP,Carson DJ,Patterson CC,Franklyn JA,Clayton DG,Peterson LB,Wicker LS,Todd JA,Gough SC.Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.Nature 2003;423:506-511[PMID:12724780 DOI:10.1038/nature01621]
159 Urcelay E,Santiago JL,de la Calle H,Martínez A,Méndez J,Ibarra JM,Maluenda C,Fernández-Arquero M,de la Concha EG.Type 1 diabetes in the Spanish population:additional factors to class II HLA-DR3 and-DR4.BMC Genomics 2005;6:56 [PMID:15842729 DOI:10.1186/1471-2164-6-56]
160 Van Autreve JE,Koeleman BP,Quartier E,Aminkeng F,Weets I,Gorus FK,Van der Auwera BJ.MICA is associated with type 1 diabetes in the Belgian population,independent of HLA-DQ.Hum Immunol 2006;67:94-101[PMID:16698430DOI:10.1016/j.humimm.2006.02.032]
161 Meager A,Visvalingam K,Peterson P,Mll K,Murumgi A,Krohn K,Eskelin P,Perheentupa J,Husebye E,Kadota Y,Willcox N.Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.PLo S Med 2006;3:e289[PMID:16784312 DOI:10.1371/journal.pmed.0030289]
162 Maurer A,Schwarting A,Kahaly GJ.[Polyglandular autoimmune syndromes].Z Rheumatol 2011;70:752-754,756 -759[PMID:22033826 DOI:10.1007/s00393-011-0786-6]
163 Alimohammadi M,Bjrklund P,Hallgren A,Pntynen N,Szinnai G,Shikama N,Keller MP,Ekwall O,Kinkel SA,Husebye ES,Gustafsson J,Rorsman F,Peltonen L,Betterle C,Perheentupa J,Akerstrm G,Westin G,Scott HS,Hollnder GA,Kmpe O.Autoimmune polyendocrine syndrome type 1 and NALP5,a parathyroid autoantigen.N Engl J Med 2008;358:1018-1028[PMID:18322283 DOI:10.1056/NEJMoa0706487]
164 Cheng MH,Anderson MS.Insights into type 1 diabetes from the autoimmune polyendocrine syndromes.Curr Opin Endocrinol Diabetes Obes 2013;20:271-278[PMID:23770732DOI:10.1097/MED.0b013e32836313eb]
165 Tsuda M,Torgerson TR,Selmi C,Gambineri E,CarneiroSampaio M,Mannurita SC,Leung PS,Norman GL,Gershwin ME.The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies.J Autoimmun 2010;35:265-268[PMID:20650610 DOI:10.1016/j.jaut.2010.06.017]
166 Cheng MH,Anderson MS.Monogenic autoimmunity.Annu Rev Immunol 2012;30:393-427[PMID:22224765 DOI:10 .1146/annurev-immunol-020711-074953]
2 Bluestone JA,Herold K,Eisenbarth G.Genetics,pathogenesis and clinical interventions in type 1 diabetes.Nature 2010;464:1293-1300[PMID:20432533]
3 Gillespie KM.Type 1 diabetes:pathogenesis and prevention.CMAJ 2006;175:165-170[PMID:16847277 DOI:10.1503/cmaj.060244]
4 Todd JA.Etiology of type 1 diabetes.Immunity 2010;32:457 -467[PMID:20412756 DOI:10.1016/j.immuni.2010.04.001]
5 Tuomilehto J.The emerging global epidemic of type 1diabetes.Curr Diab Rep 2013;13:795-804[PMID:24072479DOI:10.1007/s11892-013-0433-5]
6 DIAMOND Project Group.Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.Diabet Med 2006;23:857 -866[PMID:16911623 DOI:10.1111/j.1464-5491.2006.01925.x]
7 Cerna M,Kolostova K,Novota P,Romzova M,Cejkova P,Pinterova D,Pruhova S,Treslova L,Andel M.Autoimmune diabetes mellitus with adult onset and type 1 diabetes mellitus in children have different genetic predispositions.Ann N Y Acad Sci 2007;1110:140-150[PMID:17911429 DOI:10 .1196/annals.1423.016]
8 Xie Z,Chang C,Zhou Z.Molecular mechanisms in autoimmune type 1 diabetes:a critical review.Clin Rev Allergy Immunol 2014;47:174-192[PMID:24752371 DOI:10 .1007/s12016-014-8422-2]
9 Morahan G.Insights into type 1 diabetes provided by genetic analyses.Curr Opin Endocrinol Diabetes Obes 2012;19:263-270[PMID:22732486 DOI:10.1097/MED.0b013e328355b7fe]
10 Weinstock C,Matheis N,Barkia S,Haager MC,Janson A,MarkoviA,Bux J,Kahaly GJ.Autoimmune polyglandular syndrome type 2 shows the same HLA class II pattern as type1 diabetes.Tissue Antigens 2011;77:317-324[PMID:21388354DOI:10.1111/j.1399-0039.2011.01634.x]
11 Steck AK,Rewers MJ.Genetics of type 1 diabetes.Clin Chem 2011;57:176-185[PMID:21205883 DOI:10.1373/clinchem.2010.148221]
12 Triolo TM,Armstrong TK,Mc Fann K,Yu L,Rewers MJ,Klingensmith GJ,Eisenbarth GS,Barker JM.Additional autoimmune disease found in 33%of patients at type 1diabetes onset.Diabetes Care 2011;34:1211-1213[PMID:21430083 DOI:10.2337/dc10-1756]
13 Hansen MP,Kahaly GJ.[Autoimmune polyglandular syndromes].Dtsch Med Wochenschr 2013;138:319-326;quiz327 -328[PMID:23393002 DOI:10.1055/s-0032-1327355]
14 Frhlich-Reiterer EE,Hofer S,Kaspers S,Herbst A,Kordonouri O,Schwarz HP,Schober E,Grabert M,Holl RW.Screening frequency for celiac disease and autoimmune thyroiditis in children and adolescents with type 1 diabetes mellitus--data from a German/Austrian multicentre survey.Pediatr Diabetes 2008;9:546-553[PMID:18713134 DOI:10.1111/j.1399-5448.2008.00435.x]
15 Van den Driessche A,Eenkhoorn V,Van Gaal L,De Block C.Type 1 diabetes and autoimmune polyglandular syndrome:a clinical review.Neth J Med 2009;67:376-387[PMID:20009114]
16 International Diabetes Federation.IDF Diabetes Atlas te B.Belgium:International Diabetes Federation,2013.Availablefrom:URL:http://www.idf.org/diabetesatlas
17 Tuomi T.Type 1 and type 2 diabetes:what do they have in commonDiabetes 2005;54 Suppl 2:S40-S45[PMID:16306339]
18 Atkinson MA,Eisenbarth GS,Michels AW.Type 1 diabetes.Lancet 2014;383:69-82[PMID:23890997 DOI:10.1016/S0140-6736(13)60591-7]
19 Patterson CC,Gyürüs E,Rosenbauer J,Cinek O,Neu A,Schober E,Parslow RC,Joner G,Svensson J,Castell C,Bingley PJ,Schoenle E,Jarosz-Chobot P,UrbonaitéB,Rothe U,Krzisnik C,Ionescu-Tirgoviste C,Weets I,Kocova M,Stipancic G,Samardzic M,de Beaufort CE,Green A,Dahlquist GG,Soltész G.Trends in childhood type 1 diabetes incidence in Europe during 1989-2008:evidence of nonuniformity over time in rates of increase.Diabetologia 2012;55:2142-2147[PMID:22638547 DOI:10.1007/s00125-012-2571-8]
20 Harjutsalo V,Sjberg L,Tuomilehto J.Time trends in the incidence of type 1 diabetes in Finnish children:a cohort study.Lancet 2008;371:1777-1782[PMID:18502302 DOI:10 .1016/s0140-6736(08)60765-5]
21 Patterson CC,Dahlquist GG,Gyürüs E,Green A,Soltész G.Incidence trends for childhood type 1 diabetes in Europe during1989-2003 and predicted new cases 2005-20:a multicentre prospective registration study.Lancet 2009;373:2027-2033[PMID:19481249 DOI:10.1016/s0140-6736(09)60568-7]
22 Pundziute-LyckA,Dahlquist G,Nystrm L,Arnqvist H,Bjrk E,BlohméG,Bolinder J,Eriksson JW,Sundkvist G,Ostman J.The incidence of Type I diabetes has not increased but shifted to a younger age at diagnosis in the 0-34 years group in Sweden 1983-1998.Diabetologia 2002;45:783-791[PMID:12107721 DOI:10.1007/s00125-002-0845-2]
23 Notkins AL,Lernmark A.Autoimmune type 1 diabetes:resolved and unresolved issues.J Clin Invest 2001;108:1247-1252[PMID:11696564 DOI:10.1172/jci14257]
24 Kimpimki T,Kulmala P,Savola K,Kupila A,Korhonen S,Simell T,Ilonen J,Simell O,Knip M.Natural history of betacell autoimmunity in young children with increased genetic susceptibility to type 1 diabetes recruited from the general population.J Clin Endocrinol Metab 2002;87:4572-4579[PMID:12364437]
25 Hoppu S,Ronkainen MS,Kimpimki T,Simell S,Korhonen S,Ilonen J,Simell O,Knip M.Insulin autoantibody isotypes during the prediabetic process in young children with increased genetic risk of type 1 diabetes.Pediatr Res 2004;55:236-242[PMID:14605243 DOI:10.1203/01.pdr.0000100905.41131.3f]
26 Schmidli RS,De Aizpurua HJ,Harrison LC,Colman PG.Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects:relationship to age,sex and islet cell antibody status,and temporal profile.J Autoimmun 1994;7:55-66[PMID:8198702 DOI:10.1006/jaut.1994.1005]
27 Gan MJ,Albanese-O’Neill A,Haller MJ.Type 1 diabetes:current concepts in epidemiology,pathophysiology,clinical care,and research.Curr Probl Pediatr Adolesc Health Care 2012;42:269-291[PMID:23046732 DOI:10.1016/j.cppeds.2012.07.002]
28 Wenzlau JM,Juhl K,Yu L,Moua O,Sarkar SA,Gottlieb P,Rewers M,Eisenbarth GS,Jensen J,Davidson HW,Hutton JC.The cation efflux transporter Zn T8(Slc30A8)is a major autoantigen in human type 1 diabetes.Proc Natl Acad Sci USA 2007;104:17040-17045[PMID:17942684 DOI:10.1073/pnas.0705894104]
29 Foulis AK,Mc Gill M,Farquharson MA.Insulitis in type 1(insulin-dependent)diabetes mellitus in man--macrophages,lymphocytes,and interferon-gamma containing cells.J Pathol 1991;165:97-103[PMID:1744803 DOI:10.1002/path.1711650203]
30 Santamaria P.The long and winding road to understanding and conquering type 1 diabetes.Immunity 2010;32:437-445[PMID:20412754 DOI:10.1016/j.immuni.2010.04.003]
31 Li M,Song L J,Qin X Y.Advances in the cell ular immunological pathogenesis of type 1 diabetes.J Cell Mol Med 2014;18:749-758[PMID:24629100 DOI:10.1111/jcmm.12270]
32 Cutolo M,Paolino S,Sulli A,Smith V,Pizzorni C,Seriolo B.Vitamin D,steroid hormones,and autoimmunity.Ann N Y Acad Sci 2014;1317:39-46[PMID:24739090 DOI:10.1111/nyas.12432]
33 Keenan HA,Sun JK,Levine J,Doria A,Aiello LP,Eisenbarth G,Bonner-Weir S,King GL.Residual insulin production and pancreatic-cell turnover after 50 years of diabetes:Joslin Medalist Study.Diabetes 2010;59:2846-2853[PMID:20699420DOI:10.2337/db10-0676]
34 Gianani R.Beta cell regeneration in human pancreas.Semin Immunopathol 2011;33:23-27[PMID:21188381 DOI:10.1007/s00281-010-0235-7]
35 Kyvik KO,Green A,Beck-Nielsen H.Concordance rates of insulin dependent diabetes mellitus:a population based study of young Danish twins.BMJ 1995;311:913-917[PMID:7580548 DOI:10.1136/bmj.311.7010.913]
36 Hyttinen V,Kaprio J,Kinnunen L,Koskenvuo M,Tuomilehto J.Genetic liability of type 1 diabetes and the onset age among22 ,650 young Finnish twin pairs:a nationwide follow-up study.Diabetes 2003;52:1052-1055[PMID:12663480 DOI:10 .2337/diabetes.52.4.1052]
37 Risch N.Assessing the role of HLA-linked and unlinked determinants of disease.Am J Hum Genet 1987;40:1-14[PMID:3468804]
38 Pociot F,Mc Dermott MF.Genetics of type 1 diabetes mellitus.Genes Immun 2002;3:235-249[PMID:12140742 DOI:10.1038/sj.gene.6363875]
39 Singal DP,Blajchman MA.Histocompatibility(HL-A)antigens,lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus.Diabetes 1973;22:429-432[PMID:4541338]
40 Buzzetti R,Quattrocchi CC,NisticòL.Dissecting the genetics of type 1 diabetes:relevance for familial clustering and differences in incidence.Diabetes Metab Rev 1998;14:111-128[PMID:9679666]
41 Cudworth AG,Wolf E.The genetics of Type 1(insulindependent)diabetes.Curr Probl Clin Biochem 1983;12:45-64[PMID:6418443]
42 Nguyen C,Varney MD,Harrison LC,Morahan G.Definition of high-risk type 1 diabetes HLA-DR and HLA-DQ types using only three single nucleotide polymorphisms.Diabetes2013;62:2135-2140[PMID:23378606 DOI:10.2337/db12-1398]
43 Kockum I,Sanjeevi CB,Eastman S,Landin-Olsson M,Dahlquist G,Lernmark A.Complex interaction between HLA DR and DQ in conferring risk for childhood type 1 diabetes.Eur J Immunogenet 1999;26:361-372[PMID:10553503 DOI:10 .1046/j.1365-2370.1999.00173.x]
44 Platz P,Jakobsen BK,Morling N,Ryder LP,Svejgaard A,Thomsen M,Christy M,Kromann H,Benn J,Nerup J,Green A,Hauge M.HLA-D and-DR antigens in genetic analysis of insulin dependent diabetes mellitus.Diabetologia 1981;21:108 -115[PMID:6167481 DOI:10.1007/BF00251276]
45 Undlien DE,Lie BA,Thorsby E.HLA complex genes in type1 diabetes and other autoimmune diseases.Which genes are involvedTrends Genet 2001;17:93-100[PMID:11173119 DOI:10 .1016/S0168-9525(00)02180-6]
46 Steck AK,Bugawan TL,Valdes AM,Emery LM,Blair A,Norris JM,Redondo MJ,Babu SR,Erlich HA,Eisenbarth GS,Rewers MJ.Association of non-HLA genes with type 1diabetes autoimmunity.Diabetes 2005;54:2482-2486[PMID:16046318 DOI:10.2337/diabetes.54.8.2482]
47 Knip M,Simell O.Environmental triggers of type 1 diabetes.Cold Spring Harb Perspect Med 2012;2:a007690[PMID:22762021 DOI:10.1101/cshperspect.a007690]
48 Variation and trends in incidence of childhood diabetes in Europe.EURODIAB ACE Study Group.Lancet 2000;355:873 -876 [PMID:10752702]
49 Afonso G,Mallone R.Infectious triggers in type 1 diabetes:is there a case for epitope mimicryDiabetes Obes Metab 2013;15Suppl 3:82-88[PMID:24003924 DOI:10.1111/dom.12166]
50 Luopajrvi K,Savilahti E,Virtanen SM,Ilonen J,Knip M,Akerblom HK,Vaarala O.Enhanced levels of cow’s milk antibodies in infancy in children who develop type 1 diabetes later in childhood.Pediatr Diabetes 2008;9:434-441[PMID:18503496 DOI:10.1111/j.1399-5448.2008.00413.x]
51 Howard SG,Lee DH.What is the role of human contamination by environmental chemicals in the development of type 1diabetesJ Epidemiol Community Health 2012;66:479-481[PMID:21502091 DOI:10.1136/jech.2011.133694]
52 Mac Farlane AJ,Strom A,Scott FW.Epigenetics:deciphering how environmental factors may modify autoimmune type 1diabetes.Mamm Genome 2009;20:624-632[PMID:19697079DOI:10.1007/s00335-009-9213-6]
53 Perros P,Mc Crimmon RJ,Shaw G,Frier BM.Frequency of thyroid dysfunction in diabetic patients:value of annual screening.Diabet Med 1995;12:622-627[PMID:7554786 DOI:10 .1111/j.1464-5491.1995.tb00553.x]
54 Barera G,Bonfanti R,Viscardi M,Bazzigaluppi E,Calori G,Meschi F,Bianchi C,Chiumello G.Occurrence of celiac disease after onset of type 1 diabetes:a 6-year prospective longitudinal study.Pediatrics 2002;109:833-838[PMID:11986443 DOI:10.1542/peds.109.5.833]
55 Barker JM.Clinical review:Type 1 diabetes-associated autoimmunity:natural history,genetic associations,and screening.J Clin Endocrinol Metab 2006;91:1210-1217[PMID:16403820 DOI:10.1210/jc.2005-1679]
56 Barker JM,Yu J,Yu L,Wang J,Miao D,Bao F,Hoffenberg E,Nelson JC,Gottlieb PA,Rewers M,Eisenbarth GS.Autoantibody“subspecificity”in type 1 diabetes:risk for organ-specific autoimmunity clusters in distinct groups.Diabetes Care 2005;28:850-855[PMID:15793184]
57 Liao KP,Gunnarsson M,Kllberg H,Ding B,Plenge RM,Padyukov L,Karlson EW,Klareskog L,Askling J,Alfredsson L.Specific association of type 1 diabetes mellitus with anticyclic citrullinated peptide-positive rheumatoid arthritis.Arthritis Rheum 2009;60:653-660[PMID:19248096 DOI:10 .1002/art.24362]
58 Van Hattem S,Bootsma AH,Thio HB.Skin manifestations of diabetes.Cleve Clin J Med 2008;75:772,774,776-777 passim[PMID:19068958]
59 Nielsen NM,Westergaard T,Frisch M,Rostgaard K,Wohlfahrt J,Koch-Henriksen N,Melbye M,Hjalgrim H.Type 1 diabetes and multiple sclerosis:A Danish populationbased cohort study.Arch Neurol 2006;63:1001-1004[PMID:16831970 DOI:10.1001/archneur.63.7.1001]
60 Kota SK,Meher LK,Jammula S,Kota SK,Modi KD.Clinical profile of coexisting conditions in type 1 diabetes mellitus patients.Diabetes Metab Syndr 2012;6:70-76[PMID:23153973DOI:10.1016/j.dsx.2012.08.006]
61 Mazzarella G,Stefanile R,Camarca A,Giliberti P,Cosentini E,Marano C,Iaquinto G,Giardullo N,Auricchio S,Sette A,Troncone R,Gianfrani C.Gliadin activates HLA class I-restricted CD8+T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis.Gastroenterology2008;134:1017-1027[PMID:18395083 DOI:10.1053/j.gastro.2008.01.008]
62 Hermann R,Turpeinen H,Laine AP,Veijola R,Knip M,Simell O,SipilI,Akerblom HK,Ilonen J.HLA DR-DQencoded genetic determinants of childhood-onset type 1diabetes in Finland:an analysis of 622 nuclear families.Tissue Antigens 2003;62:162-169[PMID:12889996]
63 Kooy-Winkelaar Y,van Lummel M,Moustakas AK,Schweizer J,Mearin ML,Mulder CJ,Roep BO,Drijfhout JW,Papadopoulos GK,van Bergen J,Koning F.Gluten-specific T cells cross-react between HLA-DQ8 and the HLA-DQ2α/DQ8βtransdimer.J Immunol 2011;187:5123-5129[PMID:22013116 DOI:10.4049/jimmunol.1101179]
64 Troncone R,Discepolo V.Celiac disease and autoimmunity.J Pediatr Gastroenterol Nutr 2014;59 Suppl 1:S9-S11[PMID:24979198 DOI:10.1097/01.mpg.0000450394.30780.ea]
65 Antvorskov JC,Fundova P,Buschard K,Funda DP.Impact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.PLo S One 2012;7:e33315[PMID:22428018DOI:10.1371/journal.pone.0033315]
66 Cohn A,Sofia AM,Kupfer SS.Type 1 diabetes and celiac disease:clinical overlap and new insights into disease pathogenesis.Curr Diab Rep 2014;14:517[PMID:24952108DOI:10.1007/s11892-014-0517-x]
67 Alonso N,Soldevila B,SanmartíA,Pujol-Borrell R,MartínezCáceres E.Regulatory T cells in diabetes and gastritis.Autoimmun Rev 2009;8:659-662[PMID:19393198 DOI:10 .1016/j.autrev.2009.02.014]
68 Kahaly GJ.Polyglandular autoimmune syndromes.Eur J Endocrinol 2009;161:11-20[PMID:19411300 DOI:10.1530/eje-09-0044]
69 Neufeld M,Maclaren N,Blizzard R.Autoimmune polyglandular syndromes.Pediatr Ann 1980;9:154-162[PMID:6990358]
70 Betterle C,Zanchetta R.Update on autoimmune polyendocrine syndromes(APS).Acta Biomed 2003;74:9-33[PMID:12817789]
71 Betterle C,Greggio NA,Volpato M.Clinical review 93:Autoimmune polyglandular syndrome type 1.J Clin Endocrinol Metab 1998;83:1049-1055[PMID:9543115 DOI:10 .1210/jcem.83.4.4682]
72 Ahonen P,Myllrniemi S,SipilI,Perheentupa J.Clinical variation of autoimmune polyendocrinopathy-candidiasisectodermal dystrophy(APECED)in a series of 68 patients.N Engl J Med 1990;322:1829-1836[PMID:2348835 DOI:10 .1056/nejm199006283222601]
73 Tuomi T,Bjrses P,Falorni A,Partanen J,Perheentupa J,Lernmark A,Miettinen A.Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.J Clin Endocrinol Metab 1996;81:1488-1494[PMID:8636356 DOI:10 .1210/jcem.81.4.8636356]
74 Perheentupa J,Miettinen A.Type 1 autoimmune polyglandular disease.Ann Med Interne(Paris)1999;150:313-325[PMID:10519019]
75 Neufeld M,Maclaren NK,Blizzard RM.Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune(PGA)syndromes.Medicine(Baltimore)1981;60:355-362[PMID:7024719 DOI:10.1097/00005792-198109000-00003]
76 Zlotogora J,Shapiro MS.Polyglandular autoimmune syndrome type I among Iranian Jews.J Med Genet 1992;29:824 -826[PMID:1453436 DOI:10.1136/jmg.29.11.824]
77 Sato K,Nakajima K,Imamura H,Deguchi T,Horinouchi S,Yamazaki K,Yamada E,Kanaji Y,Takano K.A novel missense mutation of AIRE gene in a patient with autoimmune polyendocrinopathy,candidiasis and ectodermal dystrophy(APECED),accompanied with progressive muscular atrophy:case report and review of the literature in Japan.Endocr J 2002;49 :625-633[PMID:12625412 DOI:10.1507/endocrj.49.625]
78 Betterle C,Dal Pra C,Mantero F,Zanchetta R.Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes:autoantibodies,autoantigens,and their applicability in diagnosis and disease prediction.Endocr Rev 2002;23:327-364[PMID:12050123 DOI:10.1210/edrv.23.3.0466]
79 Gylling M,Tuomi T,Bjrses P,Kontiainen S,Partanen J,Christie MR,Knip M,Perheentupa J,Miettinen A.ss-cell autoantibodies,human leukocyte antigen II alleles,and type1 diabetes in autoimmune polyendocrinopathy-candidiasisectodermal dystrophy.J Clin Endocrinol Metab 2000;85:4434-4440[PMID:11134089 DOI:10.1210/jcem.85.12.7120]
80 Bjrk E,Velloso LA,Kmpe O,Karlsson FA.GAD autoantibodies in IDDM,stiff-man syndrome,and autoimmune polyendocrinesyndrome type I recognize different epitopes.Diabetes 1994;43:161 -165[PMID:7505244]
81 Velloso LA,Winqvist O,Gustafsson J,Kmpe O,Karlsson FA.Autoantibodies against a novel 51 k Da islet antigen and glutamate decarboxylase isoforms in autoimmune polyendocrine syndrome type I.Diabetologia 1994;37:61-69[PMID:8150232]
82 Husebye ES,Gebre-Medhin G,Tuomi T,Perheentupa J,Landin-Olsson M,Gustafsson J,Rorsman F,Kmpe O.Autoantibodies against aromatic L-amino acid decarboxylase in autoimmune polyendocrine syndrome type I.J Clin Endocrinol Metab 1997;82:147-150[PMID:8989249 DOI:10 .1210/jcem.82.1.3647]
83 Rorsman F,Husebye ES,Winqvist O,Bjrk E,Karlsson FA,Kmpe O.Aromatic-L-amino-acid decarboxylase,a pyridoxal phosphate-dependent enzyme,is a beta-cell autoantigen.Proc Natl Acad Sci USA 1995;92:8626-8629[PMID:7567987]
84 Anaya JM.Common mechanisms of autoimmune diseases(the autoimmune tautology).Autoimmun Rev 2012;11:781 -784[PMID:22353402 DOI:10.1016/j.autrev.2012.02.002]
85 Miller FW.Environmental agents and autoimmune diseases.Adv Exp Med Biol 2011;711:61-81[PMID:21627043]
86 Selmi C.Autoimmunity in 2011.Clin Rev Allergy Immunol2012;43:194-206[PMID:22733376DOI101007/s12016-012-8330-2]
87 Anaya JM.The diagnosis and clinical significance of polyautoimmunity.Autoimmun Rev 2014;13:423-426[PMID:24424171DOI:10.1016/j.autrev.2014.01.049]
88 Cutolo M.Autoimmune polyendocrine syndromes.Autoimmun Rev 2014;13:85-89[PMID:24055063 DOI:10.1016/j.autrev.2013.07.006]
89 Erichsen MM,Lvs K,Skinningsrud B,Wolff AB,Undlien DE,Svartberg J,Fougner KJ,Berg TJ,Bollerslev J,Mella B,Carlson JA,Erlich H,Husebye ES.Clinical,immunological,and genetic features of autoimmune primary adrenal insufficiency:observations from a Norwegian registry.J Clin Endocrinol Metab 2009;94:4882-4890[PMID:19858318 DOI:10 .1210/jc.2009-1368]
90 Betterle C,Morlin L.Autoimmune Addison’s disease.Endocr Dev 2011;20:161-172[PMID:21164269 DOI:10.1159/000321239]
91 Brenta G.Diabetes and thyroid disorders.Br J Diabetes Vasc Dis 2010;10:172-177[DOI:10.1177/1474651410371321]
92 Duntas LH,Orgiazzi J,Brabant G.The interface between thyroid and diabetes mellitus.Clin Endocrinol(Oxf)2011;75:1 -9[PMID:21521298 DOI:10.1111/j.1365-2265.2011.04029.x]
93 Kadiyala R,Peter R,Okosieme OE.Thyroid dysfunction in patients with diabetes:clinical implications and screening strategies.Int J Clin Pract 2010;64:1130-1139[PMID:20642711DOI:10.1111/j.1742-1241.2010.02376.x]
94 Kordonouri O,Klinghammer A,Lang EB,Grüters-Kieslich A,Grabert M,Holl RW.Thyroid autoimmunity in children and adolescents with type 1 diabetes:a multicenter survey.Diabetes Care 2002;25:1346-1350[PMID:12145233]
95 Denzer C,Karges B,Nke A,Rosenbauer J,Schober E,Schwab KO,Holl RW.Subclinical hypothyroidism and dyslipidemia in children and adolescents with type 1 diabetes mellitus.Eur J Endocrinol 2013;168:601-608[PMID:23384709DOI:10.1530/eje-12-0703]
96 Riley WJ,Maclaren NK,Lezotte DC,Spillar RP,Rosenbloom AL.Thyroid autoimmunity in insulin-dependent diabetes mellitus:the case for routine screening.J Pediatr 1981;99:350 -354[PMID:7264787]
97 Roldán MB,Alonso M,Barrio R.Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus.Diabetes Nutr Metab 1999;12:27-31[PMID:10517303]
98 Lambadiari V,Mitrou P,Maratou E,Raptis AE,Tountas N,Raptis SA,Dimitriadis G.Thyroid hormones are positively associated with insulin resistance early in the development of type 2 diabetes.Endocrine 2011;39:28-32[PMID:21072691DOI:10.1007/s12020-010-9408-3]
99 Horie I,Kawasaki E,Ando T,Kuwahara H,Abiru N,Usa T,Yamasaki H,Ejima E,Kawakami A.Clinical and genetic characteristics of autoimmune polyglandular syndrome type 3 variant in the Japanese population.J Clin Endocrinol Metab 2012;97:E1043-E1050[PMID:22466347 DOI:10.1210/jc.2011-3109]
100 Boelaert K,Newby PR,Simmonds MJ,Holder RL,CarrSmith JD,Heward JM,Manji N,Allahabadia A,Armitage M,Chatterjee KV,Lazarus JH,Pearce SH,Vaidya B,Gough SC,Franklyn JA.Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease.Am J Med 2010;123:183.e1-183.e9[PMID:20103030DOI:10.1016/j.amjmed.2009.06.030]
101 Lupi I,Raffaelli V,Di Cianni G,Caturegli P,Manetti L,Ciccarone AM,Bogazzi F,Mariotti S,Del Prato S,Martino E.Pituitary autoimmunity in patients with diabetes mellitus and other endocrine disorders.J Endocrinol Invest 2013;36:127 -131[PMID:23481612 DOI:10.1007/BF03346747]
102 Yoshioka K,Ohsawa A,Yoshida T,Yokoh S.Insulindependent diabetes mellitus associated with Graves’disease and idiopathic hypoparathyroidism.J Endocrinol Invest 1993;16 :643-646[PMID:8258654 DOI:10.1007/BF03347687]
103 Shapiro MS,Zamir R,Weiss E,Radnay J,Shenkman L.The polyglandular deficiency syndrome:a new variant in Persian Jews.J Endocrinol Invest 1987;10:1-7[PMID:3496374 DOI:10 .1007/BF03347139]
104 Frster G,Krummenauer F,Kühn I,Beyer J,Kahaly G.[Polyglandular autoimmune syndrome type II:epidemiology and forms of manifestation].Dtsch Med Wochenschr 1999;124:1476-1481[PMID:10629665 DOI:10.1055/s-2008-1035684]
105 Dittmar M,Kahaly GJ.Polyglandular autoimmune syndromes:immunogenetics and long-term follow-up.J Clin Endocrinol Metab 2003;88:2983-2992[PMID:12843130 DOI:10 .1210/jc.2002-021845]
106 Schatz DA,Winter WE.Autoimmune polyglandular syndrome.II:Clinical syndrome and treatment.Endocrinol Metab Clin North Am 2002;31:339-352[PMID:12092454]
107 Santamaria P,Barbosa JJ,Lindstrom AL,Lemke TA,Goetz FC,Rich SS.HLA-DQB1-associated susceptibility that distinguishes Hashimoto‘s thyroiditis from Graves‘disease in type I diabetic patients.J Clin Endocrinol Metab 1994;78:878 -883[PMID:8157715 DOI:10.1210/jcem.78.4.8157715]
108 Huang W,Connor E,Rosa TD,Muir A,Schatz D,Silverstein J,Crockett S,She JX,Maclaren NK.Although DR3-DQB1*0201may be associated with multiple component diseases of the autoimmune polyglandular syndromes,the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in betacell autoimmunity.J Clin Endocrinol Metab 1996;81:2559-2563[PMID:8675578 DOI:10.1210/jcem.81.7.8675578]
109 Chikuba N,Akazawa S,Yamaguchi Y,Kawasaki E,Takino H,Yoshimoto M,Ohe N,Yamashita K,Yano A,Nagataki S.Immunogenetic heterogeneity in type 1(insulin-dependent)diabetes among Japanese--class II antigen and autoimmune thyroid disease.Diabetes Res Clin Pract 1995;27:31-37[PMID:7781492 DOI:10.1016/0168-8227(94)01025-U]
110 Chuang LM,Wu HP,Chang CC,Tsai WY,Chang HM,Tai TY,Lin BJ.HLA DRB1/DQA1/DQB1 haplotype determines thyroid autoimmunity in patients with insulin-dependent diabetes mellitus.Clin Endocrinol(Oxf)1996;45:631-636[PMID:8977762 DOI:10.1046/j.1365-2265.1996.00857.x]
111 Kim EY,Shin CH,Yang SW.Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease.Autoimmunity 2003;36 :177-181[PMID:12911285 DOI:10.1080/0891693031000101279]
112 Golden B,Levin L,Ban Y,Concepcion E,Greenberg DA,Tomer Y.Genetic analysis of families with autoimmune diabetes and thyroiditis:evidence for common and unique genes.J Clin Endocrinol Metab 2005;90:4904-4911[PMID:15928253 DOI:10.1210/jc.2004-2236]
113 Villano MJ,Huber AK,Greenberg DA,Golden BK,Concepcion E,Tomer Y.Autoimmune thyroiditis and diabetes:dissecting the joint genetic susceptibility in a large cohort of multiplex families.J Clin Endocrinol Metab 2009;94:1458-1466[PMID:19141582 DOI:10.1210/jc.2008-2193]
114 Dultz G,Matheis N,Dittmar M,Bender K,Kahaly GJ.CTLA-4 CT60 polymorphism in thyroid and polyglandular autoimmunity.Horm Metab Res 2009;41:426-429[PMID:19530270]
115 Awata T,Kawasaki E,Tanaka S,Ikegami H,Maruyama T,Shimada A,Nakanishi K,Kobayashi T,Iizuka H,Uga M,Kawabata Y,Kanazawa Y,Kurihara S,Osaki M,Katayama S.Association of type 1 diabetes with two Loci on 12q13 and16 p13 and the influence coexisting thyroid autoimmunity in Japanese.J Clin Endocrinol Metab 2009;94:231-235[PMID:18940880 DOI:10.1210/jc.2008-0718]
116 Dultz G,Matheis N,Dittmar M,Rhrig B,Bender K,Kahaly GJ.The protein tyrosine phosphatase non-receptor type22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes.Thyroid 2009;19 :143-148[PMID:19090780 DOI:10.1089/thy.2008.0301]
117 Smyth D,Cooper JD,Collins JE,Heward JM,Franklyn JA,Howson JM,Vella A,Nutland S,Rance HE,Maier L,Barratt BJ,Guja C,Ionescu-Trgoviste C,Savage DA,Dunger DB,Widmer B,Strachan DP,Ring SM,Walker N,Clayton DG,Twells RC,Gough SC,Todd JA.Replication of an association between the lymphoid tyrosine phosphatase locus(LYP/PTPN22)with type 1 diabetes,and evidence for its role as a general autoimmunity locus.Diabetes 2004;53:3020-3023[PMID:15504986]
118 Kawasaki E,Awata T,Ikegami H,Kobayashi T,Maruyama T,Nakanishi K,Shimada A,Uga M,Kurihara S,Kawabata Y,Tanaka S,Kanazawa Y,Lee I,Eguchi K.Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene(PTPN22):association between a promoter polymorphism and type 1 diabetes in Asian populations.Am J Med Genet A 2006;140:586-593[PMID:16470599 DOI:10 .1002/ajmg.a.31124]
119 Bottini N,Musumeci L,Alonso A,Rahmouni S,Nika K,Rostamkhani M,Mac Murray J,Meloni GF,Lucarelli P,Pellecchia M,Eisenbarth GS,Comings D,Mustelin T.A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.Nat Genet 2004;36:337-338[PMID:15004560 DOI:10.1038/ng1323]
120 van der Vliet HJ,Nieuwenhuis EE.IPEX as a result of mutations in FOXP3.Clin Dev Immunol 2007;2007:89017[PMID:18317533 DOI:10.1155/2007/89017]
121 Wildin RS,Smyk-Pearson S,Filipovich AH.Clinical and molecular features of the immunodysregulation,polyendocrinopathy,enteropathy,X linked(IPEX)syndrome.J Med Genet 2002;39:537-545[PMID:12161590]
122 Long SA,Cerosaletti K,Bollyky PL,Tatum M,Shilling H,Zhang S,Zhang ZY,Pihoker C,Sanda S,Greenbaum C,Buckner JH.Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+)regulatory T-cells of type 1 diabetic subjects.Diabetes 2010;59:407-415[PMID:19875613 DOI:10.2337/db09-0694]
123 Husebye ES,Anderson MS.Autoimmune polyendocrine syndromes:clues to type 1 diabetes pathogenesis.Immunity 2010;32 :479-487[PMID:20412758 DOI:10.1016/j.immuni.2010.03.016]
124 Tomer Y,Menconi F.Type 1 diabetes and autoimmune thyroiditis:the genetic connection.Thyroid 2009;19:99-102[PMID:19191741 DOI:10.1089/thy.2008.1565]
125 Bingley PJ,Christie MR,Bonifacio E,Bonfanti R,Shattock M,Fonte MT,Bottazzo GF,Gale EA.Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives.Diabetes 1994;43:1304-1310[PMID:7926304]
126 Deja G,Myrda A,Jarosz-Chobot P,Siekiera U.The assessment of autoimmunological status and prevalence ofdifferent forms of celiac disease among children with type 1diabetes mellitus and celiac disease.Mediators Inflamm 2008;2008:285989[PMID:18437226 DOI:10.1155/2008/285989]
127 Irvine WJ,Mc Callum CJ,Gray RS,Campbell CJ,Duncan LJ,Farquhar JW,Vaughan H,Morris PJ.Pancreatic islet-cell antibodies in diabetes mellitus correlated with the duration and type of diabetes,coexistent autoimmune disease,and HLA type.Diabetes 1977;26:138-147[PMID:320073]
128 Kawasaki E.Zn T8 and type 1 diabetes.Endocr J 2012;59:531 -537[PMID:22447136]
129 Orban T,Sosenko JM,Cuthbertson D,Krischer JP,Skyler JS,Jackson R,Yu L,Palmer JP,Schatz D,Eisenbarth G.Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.Diabetes Care 2009;32 :2269-2274[PMID:19741189 DOI:10.2337/dc09-0934]
130 Petruzelkova L,Ananieva-Jordanova R,Vcelakova J,Vesely Z,Stechova K,Lebl J,Dusatkova P,Sumnik Z,Coles R,Powell M,Furmaniak J,Rees Smith B,Kolouskova S.The dynamic changes of zinc transporter 8 autoantibodies in Czech children from the onset of Type 1 diabetes mellitus.Diabet Med 2014;31:165-171[PMID:23952619 DOI:10.1111/dme.12308]
131 Skrstrand H,Lernmark A,Vaziri-Sani F.Antigenicity and epitope specificity of Zn T8 autoantibodies in type 1 diabetes.Scand J Immunol 2013;77:21-29[PMID:23126564 DOI:10 .1111/sji.12008]
132 Trn C,Mueller PW,Schlosser M,Bonifacio E,Bingley PJ.Diabetes Antibody Standardization Program:evaluation of assays for autoantibodies to glutamic acid decarboxylase and islet antigen-2.Diabetologia 2008;51:846-852[PMID:18373080DOI:10.1007/s00125-008-0967-2]
133 Vaziri-Sani F,Oak S,Radtke J,Lernmark K,Lynch K,Agardh CD,Cilio CM,Lethagen AL,Ortqvist E,LandinOlsson M,Trn C,Hampe CS.Zn T8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset.Autoimmunity 2010;43:598-606[PMID:20298127 DOI:10.3109 /08916930903555927]
134 Zhang L,Eisenbarth GS.Prediction and prevention of Type1 diabetes mellitus.J Diabetes 2011;3:48-57[PMID:21073664DOI:10.1111/j.1753-0407.2010.00102.x]
135 Thomson G,Robinson WP,Kuhner MK,Joe S,Mac Donald MJ,Gottschall JL,Barbosa J,Rich SS,Bertrams J,Baur MP.Genetic heterogeneity,modes of inheritance,and risk estimates for a joint study of Caucasians with insulindependent diabetes mellitus.Am J Hum Genet 1988;43:799 -816[PMID:3057885]
136 Cooper GS,Bynum ML,Somers EC.Recent insights in the epidemiology of autoimmune diseases:improved prevalence estimates and understanding of clustering of diseases.J Autoimmun 2009;33:197-207[PMID:19819109 DOI:10.1016/j.jaut.2009.09.008]
137 Unnikrishnan AG,Kumaravel V,Nair V,Rao A,Jayakumar RV,Kumar H,Sanjeevi CB.TSH receptor antibodies in subjects with type 1 diabetes mellitus.Ann N Y Acad Sci 2006;1079:220-225[PMID:17130558 DOI:10.1196/annals.1375.034]
138 Premawardhana LD,Wijeyaratne CN,Chen S,Wijesuriya M,Illangasekera U,Brooking H,Amoroso M,Jeffreys J,Bolton J,Lazarus JH,Furmaniak J,Rees Smith B.Islet cell,thyroid,adrenal and celiac disease related autoantibodies in patients with Type 1 diabetes from Sri Lanka.J Endocrinol Invest 2006;29 :968-974[PMID:17259793]
139 Orgiazzi J.Anti-TSH receptor antibodies in clinical practice.Endocrinol Metab Clin North Am 2000;29:339-355,vii[PMID:10874533]
140 Pinto AL,Dantas JR,Araujo D,Barone B,de Souza Papi J,de Oliveira JE,Zajdenverg L,Rodacki M.Anti-parietal cell antibodies and pernicious anemia in patients with type 1diabetes mellitus and multiethnic background.Diabetes Res Clin Pract 2013;102:e41-e43[PMID:24083984 DOI:10.1016/j.diabres.2013.08.008]
141 Perros P,Singh RK,Ludlam CA,Frier BM.Prevalence of pernicious anaemia in patients with Type 1 diabetes mellitus and autoimmune thyroid disease.Diabet Med 2000;17:749 -751[PMID:11110510]
142 Caturegli P,Newschaffer C,Olivi A,Pomper MG,Burger PC,Rose NR.Autoimmune hypophysitis.Endocr Rev 2005;26 :599-614[PMID:15634713 DOI:10.1210/er.2004-0011]
143 Lvs K,Husebye ES.High prevalence and increasing incidence of Addison’s disease in western Norway.Clin Endocrinol(Oxf)2002;56:787-791[PMID:12072049]
144 Ban Y,Davies TF,Greenberg DA,Concepcion ES,Tomer Y.The influence of human leucocyte antigen(HLA)genes on autoimmune thyroid disease(AITD):results of studies in HLA-DR3 positive AITD families.Clin Endocrinol(Oxf)2002;57 :81-88[PMID:12100074]
145 Brozzetti A,Marzotti S,Tortoioli C,Bini V,Giordano R,Dotta F,Betterle C,De Bellis A,Arnaldi G,Toscano V,Arvat E,Bellastella A,Mantero F,Falorni A.Cytotoxic T lymphocyte antigen-4 Ala17 polymorphism is a genetic marker of autoimmune adrenal insufficiency:Italian association study and meta-analysis of European studies.Eur J Endocrinol 2010;162 :361-369[PMID:19884265 DOI:10.1530/eje-09-0618]
146 Criswell LA,Pfeiffer KA,Lum RF,Gonzales B,Novitzke J,Kern M,Moser KL,Begovich AB,Carlton VE,Li W,Lee AT,Ortmann W,Behrens TW,Gregersen PK.Analysis of families in the multiple autoimmune disease genetics consortium(MADGC)collection:the PTPN22 620W allele associates with multiple autoimmune phenotypes.Am J Hum Genet 2005;76:561 -571[PMID:15719322 DOI:10.1086/429096]
147 Gambelunghe G,Falorni A,Ghaderi M,Laureti S,Tortoioli C,Santeusanio F,Brunetti P,Sanjeevi CB.Microsatellite polymorphism of the MHC class I chain-related(MIC-A and MIC-B)genes marks the risk for autoimmune Addison’s disease.J Clin Endocrinol Metab 1999;84:3701-3707[PMID:10523017 DOI:10.1210/jcem.84.10.6069]
148 Heward JM,Allahabadia A,Daykin J,Carr-Smith J,Daly A,Armitage M,Dodson PM,Sheppard MC,Barnett AH,Franklyn JA,Gough SC.Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves’disease:replication using a population case control and family-based study.J Clin Endocrinol Metab 1998;83:3394-3397[PMID:9768636DOI:10.1210/jcem.83.10.5137]
149 Ide M,Dittmar M,Wurm M,Kanitz M,Kahaly GJ.[Polymorphisms of MICA microsatellites in thyroidal autoimmunity].Med Klin(Munich)2007;102:11-15[PMID:17221346 DOI:10 .1007/s00063-007-1001-z]
150 Kavvoura FK,Ioannidis JP.CTLA-4 gene polymorphisms and susceptibility to type 1 diabetes mellitus:a Hu GE Review and meta-analysis.Am J Epidemiol 2005;162:3-16[PMID:15961581 DOI:10.1093/aje/kwi165]
151 Menconi F,Monti MC,Greenberg DA,Oashi T,Osman R,Davies TF,Ban Y,Jacobson EM,Concepcion ES,Li CW,Tomer Y.Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice.Proc Natl Acad Sci USA 2008;105:14034-14039[PMID:18779568 DOI:10.1073/pnas.0806584105]
152 Park Y,Lee H,Sanjeevi CB,Eisenbarth GS.MICA polymorphism is associated with type 1 diabetes in the Korean population.Diabetes Care 2001;24:33-38[PMID:11194237]
153 Roycroft M,Fichna M,Mc Donald D,Owen K,Zurawek M,Gryczyńska M,Januszkiewicz-Lewandowska D,Fichna P,Cordell H,Donaldson P,Nowak J,Pearce S.The tryptophan620 allele of the lymphoid tyrosine phosphatase(PTPN22)gene predisposes to autoimmune Addison’s disease.Clin Endocrinol(Oxf)2009;70:358-362[PMID:18710467 DOI:10 .1111/j.1365-2265.2008.03380.x]
154 Saleh HM,Rohowsky N,Leski M.The CTLA4-819 C/T and+49 A/G dimorphisms are associated with Type 1 diabetes in Egyptian children.Indian J Hum Genet 2008;14:92-98[PMID:20300303 DOI:10.4103/0971-6866.45001]
155 Sanjeevi CB,Sedimbi SK,Landin-Olsson M,Kockum I,Lernmark A.Risk conferred by HLA-DR and DQ for type1 diabetes in 0-35-year age group in Sweden.Ann N Y Acad Sci 2008;1150:106-111[PMID:19120278 DOI:10.1196/annals.1447.061]
156 Stenszky V,Kozma L,Balázs C,Rochlitz S,Bear JC,Farid NR.The genetics of Graves’disease:HLA and disease susceptibility.J Clin Endocrinol Metab 1985;61:735-740[PMID:3861611 DOI:10.1210/jcem-61-4-735]
157 Thorsby E.Invited anniversary review:HLA associated diseases.Hum Immunol 1997;53:1-11[PMID:9127141 DOI:10 .1016/s0198-8859(97)00024-4]
158 Ueda H,Howson JM,Esposito L,Heward J,Snook H,Chamberlain G,Rainbow DB,Hunter KM,Smith AN,Di Genova G,Herr MH,Dahlman I,Payne F,Smyth D,Lowe C,Twells RC,Howlett S,Healy B,Nutland S,Rance HE,Everett V,Smink LJ,Lam AC,Cordell HJ,Walker NM,Bordin C,Hulme J,Motzo C,Cucca F,Hess JF,Metzker ML,Rogers J,Gregory S,Allahabadia A,Nithiyananthan R,TuomilehtoWolf E,Tuomilehto J,Bingley P,Gillespie KM,Undlien DE,Rnningen KS,Guja C,Ionescu-Trgovite C,Savage DA,Maxwell AP,Carson DJ,Patterson CC,Franklyn JA,Clayton DG,Peterson LB,Wicker LS,Todd JA,Gough SC.Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.Nature 2003;423:506-511[PMID:12724780 DOI:10.1038/nature01621]
159 Urcelay E,Santiago JL,de la Calle H,Martínez A,Méndez J,Ibarra JM,Maluenda C,Fernández-Arquero M,de la Concha EG.Type 1 diabetes in the Spanish population:additional factors to class II HLA-DR3 and-DR4.BMC Genomics 2005;6:56 [PMID:15842729 DOI:10.1186/1471-2164-6-56]
160 Van Autreve JE,Koeleman BP,Quartier E,Aminkeng F,Weets I,Gorus FK,Van der Auwera BJ.MICA is associated with type 1 diabetes in the Belgian population,independent of HLA-DQ.Hum Immunol 2006;67:94-101[PMID:16698430DOI:10.1016/j.humimm.2006.02.032]
161 Meager A,Visvalingam K,Peterson P,Mll K,Murumgi A,Krohn K,Eskelin P,Perheentupa J,Husebye E,Kadota Y,Willcox N.Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.PLo S Med 2006;3:e289[PMID:16784312 DOI:10.1371/journal.pmed.0030289]
162 Maurer A,Schwarting A,Kahaly GJ.[Polyglandular autoimmune syndromes].Z Rheumatol 2011;70:752-754,756 -759[PMID:22033826 DOI:10.1007/s00393-011-0786-6]
163 Alimohammadi M,Bjrklund P,Hallgren A,Pntynen N,Szinnai G,Shikama N,Keller MP,Ekwall O,Kinkel SA,Husebye ES,Gustafsson J,Rorsman F,Peltonen L,Betterle C,Perheentupa J,Akerstrm G,Westin G,Scott HS,Hollnder GA,Kmpe O.Autoimmune polyendocrine syndrome type 1 and NALP5,a parathyroid autoantigen.N Engl J Med 2008;358:1018-1028[PMID:18322283 DOI:10.1056/NEJMoa0706487]
164 Cheng MH,Anderson MS.Insights into type 1 diabetes from the autoimmune polyendocrine syndromes.Curr Opin Endocrinol Diabetes Obes 2013;20:271-278[PMID:23770732DOI:10.1097/MED.0b013e32836313eb]
165 Tsuda M,Torgerson TR,Selmi C,Gambineri E,CarneiroSampaio M,Mannurita SC,Leung PS,Norman GL,Gershwin ME.The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies.J Autoimmun 2010;35:265-268[PMID:20650610 DOI:10.1016/j.jaut.2010.06.017]
166 Cheng MH,Anderson MS.Monogenic autoimmunity.Annu Rev Immunol 2012;30:393-427[PMID:22224765 DOI:10 .1146/annurev-immunol-020711-074953]